[{"Assets_0_Q1_USD":5287128000.0,"EarningsPerShareBasic_1_Q1_USD":0.77,"EarningsPerShareDiluted_1_Q1_USD":0.75,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":162359000.0,"NetIncomeLoss_1_Q1_USD":45991000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":444613000.0,"StockholdersEquity_0_Q1_USD":2786571000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":61178000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":59928000.0,"Ticker":"JAZZ","CIK":"1232524","name":"JAZZ PHARMACEUTICALS PLC","OfficialName":"Jazz Pharmaceuticals plc Common Stock (Ireland)","form":"10-Q","period":"20180331","fy":"2018.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"10281986580.0","Country":"Ireland","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180508"}]